CSIMarket
 


Sangui Biotech International Inc  (SGBI)
Other Ticker:  
 


Sangui Biotech International Inc's Net Cash Flow Margin by quarter

Trends, Rankings, Statistics



SGBI Net Cash Flow Margin (Mar 31 2022)
III. Quarter
(Dec 31 2021)
II. Quarter
(Sep 30 2021)
I. Quarter
(Jun 30 2021)
IV. Quarter
(Mar 31 2021)
III. Quarter
Y / Y Revenue Change -15.24 % 107.37 % -6.64 % 78.72 % 129.96 %
Seq. Revenue Change -19.02 % 19.46 % 34.19 % -34.7 % 98.11 %
Revenue In Millions $0.02 $0.02 $0.02 $0.01 $0.02
Net Cash Flow Margin - -23.18 % -88.13 % - 13.12 %
Net Cash Flow Margin Total Ranking # 186 # # # 498 # 1454
Net Cash Flow In Millions $0.06 $-0.01 $-0.02 $0.02 $0.00
Y / Y Net Cash Flow Change - - - - -
Seq. Net Cash Flow Change - - - - -


Commenting Third Quarter 2022 Net Cash Flow Margin
Company's Net Cash Flow Margin improved in III. Quarter to 330.54 %, above company's average Net Cash Flow Margin.

Observing third quarter 2022 results within Biotechnology & Pharmaceuticals industry 24 other companies have achieved higher Net Cash Flow Margin. While Net Cash Flow Margin overall ranking has deteriorated compare to previous quarter from to 186.

SGBI's Net Cash Flow Margin third quarter 2022 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 25
Healthcare Sector # 63
Overall # 186

Net Cash Flow Margin Statistics
High Average Low
529.84 % 178.56 % 13.12 %
(Dec 31 2015)   (Mar 31 2021)




Other Net Cash Flow Margin Profitability Ratios
SGBI's Cumulative Net Cash Flow Margin
Biotechnology & Pharmaceuticals Industry Net Cash Flow Margin Trends and Statistics
Healthcare Sector Net Cash Flow Margin Statistics
Net Cash Flow Margin Profitability Trends for overall market
SGBI's Net Cash Flow Margin Profitability versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Margin
Lowest Ranking Net Cash Flow Margin
Net Cash Flow Margin Profit Margin for SGBI's Competitors
Net Cash Flow Margin Profit Margin for Sangui Biotech International Inc's Suppliers
Net Cash Flow Margin Profit Margin for SGBI's Customers

You may also want to know
SGBI's Annual Growth Rates SGBI's Profitability Ratios SGBI's Asset Turnover Ratio SGBI's Dividend Growth
SGBI's Roe SGBI's Valuation Ratios SGBI's Financial Strength Ratios SGBI's Net Cash Flow Growth
SGBI's Roa SGBI's Inventory Turnover Ratio SGBI's Growth Rates SGBI's Dividend Comparisons


Companies with similar Net Cash Flow Margin in the quarter ending Mar 31 2022, within Biotechnology & Pharmaceuticals Industry Net Cash Flow MarginMar 31 2022 MRQ Net Cash FlowMar 31 2022 MRQ Revenue
Tarsus Pharmaceuticals Inc.  682.37 %$ 3.678 $ 0.539 
Aclaris Therapeutics Inc.  618.93 %$ 8.993 $ 1.453 
Solid Biosciences Inc.  549.35 %$ 10.575 $ 1.925 
Urogen Pharma Ltd.  444.87 %$ 60.342 $ 13.564 
Lineage Cell Therapeutics Inc.  426.37 %$ 22.329 $ 5.237 
Cue Biopharma Inc.  355.60 %$ 3.556 $ 1.000 
Sangui Biotech International Inc  330.54 %$ 0.059 $ 0.018 
Anavex Life Sciences Corp.  197.55 %$ 2.196 $ 1.112 
Theralink Technologies Inc.  166.59 %$ 0.032 $ 0.020 
U.s. Lighting Group Inc.  155.26 %$ 0.118 $ 0.076 
Therapeutic Solutions International Inc.  84.40 %$ 0.072 $ 0.085 
Cannabis Global Inc.  82.10 %$ 0.515 $ 0.627 
Iterum Therapeutics Plc  75.62 %$ 3.915 $ 5.177 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ROMVL's Profile

Stock Price

ROMVL's Financials

Business Description

Fundamentals

Charts & Quotes

ROMVL's News

Suppliers

ROMVL's Competitors

Customers & Markets

Economic Indicators

ROMVL's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071